PRESS RELEASE published on 01/10/2024 at 22:30, 2 years 4 months ago CATHETER PRECISION, INC. (VTAK) Reports Unaudited Preliminary Fourth Quarter and Full Year 2023 Results Catheter Precision, Inc. (VTAK:NYSE/American), a US-based medical device company, announced unaudited preliminary annual and fourth quarter results of 2023. These results included total revenues, cash on hand, total assets, shareholders equity, and preliminary net loss. The company also highlighted key achievements of the year, including sales and clinical personnel onboarding and training, product launches, study enrollments, and intellectual property expansion. CEO David Jenkins expressed optimism for 2024, emphasizing the momentum and market potential of their products. The company cautioned that the results are subject to finalization, internal review, potential adjustments, and external audit, with consideration for potential impact from impairment analysis and future royalties. For more information, please refer to the original press release on accesswire.com. Financial Results Catheter Precision 2024 Outlook Medical Device David Jenkins
PRESS RELEASE published on 01/03/2024 at 14:00, 2 years 4 months ago Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of Directors Catheter Precision, a US-based medical device company, has announced changes to its executive management and board of directors, including the appointment of Margrit Thomassen as the interim Chief Financial Officer and the naming of David Jenkins as the Chief Executive Officer. The company, focused on electrophysiology products, aims to continue its growth and meet the needs of patients, hospitals, and physicians. The announcement also includes the resignation of Susanne Meline from the Board of Directors and the appointment of John Francis as her replacement. These changes are part of the company's strategic plan for the upcoming year. Electrophysiology Products Medical Device Company Catheter Precision Executive Management Interim Chief Financial Officer
PRESS RELEASE published on 01/02/2024 at 14:00, 2 years 4 months ago Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market Catheter Precision, Inc. announced the allowance of two new patents (No. 6288592 and No. 015023977-0001) in Great Britain and the European Market for its LockeT product line, further solidifying the company's IP position. These patents demonstrate the company's commitment to the uniqueness of the closure product design, strengthening its global presence in the electrophysiology products market. Catheter Precision Inc. LockeT Patents Electrophysiology Products Medical Device Company Great Britain And European Market
PRESS RELEASE published on 12/22/2023 at 14:00, 2 years 4 months ago Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
PRESS RELEASE published on 12/18/2023 at 14:00, 2 years 4 months ago CATHETER PRECISION, INC. Reports Filing of 10-Q and Second Quarter Results of Operations
PRESS RELEASE published on 12/05/2023 at 14:00, 2 years 5 months ago Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Emerging Growth Conference on December 6, 2023 Catheter Precision, Inc. (NYSE American:VTAK) to present its innovative non-invasive 3D mapping system, VIVO, at the Emerging Growth Conference on December 6, 2023. The event offers an opportunity for real-time interaction with the CEO Catheter Precision Inc. Medical Device Company VIVO Emerging Growth Conference 3D Mapping System
PRESS RELEASE published on 11/20/2023 at 14:00, 2 years 5 months ago Catheter Precision's (VTAK) First Successful VIVO(TM) Cases Completed in Croatia Sets Stage for Expansion into South-Eastern Europe
PRESS RELEASE published on 10/12/2023 at 14:00, 2 years 6 months ago Catheter Precision’s VIVO is Now Eligible for National Reimbursement in the UK
PRESS RELEASE published on 10/10/2023 at 14:00, 2 years 7 months ago Catheter Precision Showcasing its Innovative 3D Mapping System
PRESS RELEASE published on 09/07/2023 at 14:00, 2 years 8 months ago Catheter Precision, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Published on 05/09/2026 at 01:30, 2 days 1 hour ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 3 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 11 hours 13 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 13 hours 18 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 15 hours 33 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 8 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 6 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 8 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 8 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 8 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 8 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 8 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL